版本:
中国

BRIEF-Essa Pharma provides clinical study update and announces presentations at the American Association for Cancer Research annual meeting

April 3 Essa Pharma Inc

* Essa Pharma provides clinical study update and announces presentations at the American Association for Cancer Research annual meeting

* Essa Pharma Inc - EPI-506 continues to be very well-tolerated through six patient cohorts at escalating doses in phase 1 dose trial

* Essa Pharma - intends to submit data from phase 1 clinical trial to scientific meeting, sees announcing updated results by end of Q2 2017 for EPI-506 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐